Casdin Capital’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-498,427
| Closed | -$21.7M | – | 39 |
|
|
2023
Q3 | $21.7M | Buy |
498,427
+474,613
| +1,993% | +$20.7M | 2.4% | 14 |
|
|
2023
Q2 | $860K | Sell |
23,814
-486,186
| -95% | -$17.6M | 0.08% | 38 |
|
|
2023
Q1 | $19M | Buy |
510,000
+35,000
| +7% | +$1.3M | 1.56% | 19 |
|
|
2022
Q4 | $21.5M | Buy |
475,000
+225,000
| +90% | +$10.2M | 1.67% | 17 |
|
|
2022
Q3 | $17.5M | Buy |
250,000
+153,000
| +158% | +$10.7M | 1.15% | 18 |
|
|
2022
Q2 | $6.51M | Sell |
97,000
-5,500
| -5% | -$369K | 0.55% | 28 |
|
|
2022
Q1 | $8.43M | Buy |
+102,500
| New | +$8.43M | 0.38% | 38 |
|